Gayeoun Kim

Gayeoun Kim

Auto-generated profile, based on publicly available information

Gayeoun Kim

Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
SKSOO-MI KWEON
SOO-MI KWEON
GKGayeoun Kim
Gayeoun Kim
YJYunseong Jeong
Yunseong Jeong
WHWendong Huang
Wendong Huang
JLJu-Seog Lee
Ju-Seog Lee
KLKeane Lai
Keane Lai
Hepatocellular carcinoma (HCC) ranks worldwide as one of the most lethal cancers. In spite of the vast existing knowledge about HCC, the pathogenesis of HCC is not completely understood. Discovery of novel genes that contribute to HCC pathogenesis will provide new insights for better understanding and treating HCC. The relatively obscure gene midnolin has been studied for over two decades; however, its biological roles are largely unknown. Our study is the first to demonstrate the functional significance of midnolin in HCC/cancer: Midnolin expression correlates with poor prognosis in HCC patients, and suppression of midnolin severely inhibits tumorigenicity of HCC cells in vitro and in mice and disrupts retinoic acid/lipid metabolism in these cells.